CN102240308A - Application of valeriana jatamansi jones to preparation of anti-canine parvovirus medicament - Google Patents

Application of valeriana jatamansi jones to preparation of anti-canine parvovirus medicament Download PDF

Info

Publication number
CN102240308A
CN102240308A CN2010101698120A CN201010169812A CN102240308A CN 102240308 A CN102240308 A CN 102240308A CN 2010101698120 A CN2010101698120 A CN 2010101698120A CN 201010169812 A CN201010169812 A CN 201010169812A CN 102240308 A CN102240308 A CN 102240308A
Authority
CN
China
Prior art keywords
canine parvovirus
application
preparation
medicament
parvovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010101698120A
Other languages
Chinese (zh)
Inventor
夏咸柱
王承宇
黄耕
杨松涛
高玉伟
王铁成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Military Veterinary Academy of Military Medical Sciences PLA
Original Assignee
Institute of Military Veterinary Academy of Military Medical Sciences PLA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Military Veterinary Academy of Military Medical Sciences PLA filed Critical Institute of Military Veterinary Academy of Military Medical Sciences PLA
Priority to CN2010101698120A priority Critical patent/CN102240308A/en
Publication of CN102240308A publication Critical patent/CN102240308A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to application of valeriana jatamansi jones to preparation of an anti-canine parvovirus medicament. An oral preparation, prepared from the Chinese medicament valeriana jatamansi jones serving as a medicinal ingredient and medicinal auxiliary materials, is taken orally by a dog infected with the parvovirus, so that the canine parvovirus antigen is detected to be negative, and symptoms such as decreased appetite, fever, irregular bowel movement and the like caused by the canine parvovirus are treated. Compared with the traditional method for performing treatment by using antibiotic, the application of valeriana jatamansi jones has the characteristics of high pertinence, high safety, remarkable curative effect and the like.

Description

The application of Rhizoma valerianae latifoliae in preparation anti-dog parvovirus medicine
Technical field
The present invention relates to the application of Rhizoma valerianae latifoliae in preparation anti-dog parvovirus medicine, belong to field of veterinary.
Background technology
The Canine Parvovirus enteritis is that a kind of acute with vomiting, dysentery etc. clinically, gastroenteritis haemorrhagica that is caused by Canine Parvovirus is the infectious disease of cardinal symptom.Its sickness rate height, infectiousness is strong, and the mortality rate height is one of the most serious infectious disease of foster dog industry of harm China and fur-bearing animal aquaculture, and the economic loss that therefore cause every year is serious.
Can not determine under the situation of cause of disease clinically at present, mainly the way that prevents secondary infection and energize mixture maintenance homergy by broad-spectrum antiviral medicament treatment, antibiotic.These methods lack specific aim and curative effect is very little, and a large amount of uses of what is more important antibiotic and antiviral drugs also can cause the appearance of drug resistance strain, so are badly in need of wanting a kind of medicine of safety and environmental protection in clinical and the production practices.
Rhizoma valerianae latifoliae (Valeriana jatamansi Jones) has another name called Herba Asari, tiger seven, Indian Rhizoma et radix valerianae etc., is the Valerianaceae valerian.The name beginning of Rhizoma valerianae latifoliae is stated from Compendium of Material Medica, and it is said: " suffering, temperature, nontoxic "." Rhizoma valerianae latifoliae goes out in the another name for Sichuan Province Xi Maozhou pine fence mountain.Grass roots also, black has thick palpus, shape such as Aranea and Rhizoma Ligustici, Rhizoma Chuanxiong, fragrant odour ".It can " ward off pestilence, attacked by pestiferous factors be evil smart, terrible gas consumptive disease with protracted syncope." version Chinese Pharmacopoeia (an one) was once recorded 1977 years.Among the peoplely ache, and can be calm, pleasant, help digestion, control dermexanthesis, sealing and let out etc. with its treatment trusted subordinate pain, rheumatic numbness and muscles, a plurality of nationalitys such as the Dong nationality, Miao ethnic group and Naxi with it as treatment diarrheal good medicine.Yet there is not the people to be used for dog as medicine as yet and infects the parvovirus treatment with it.
Summary of the invention
The present invention is crude drug with the Rhizoma valerianae latifoliae, make granule after the pulverizing and directly take or be equipped with acceptable accessories to dog, take to dog as starch, PEG6000, magnesium stearate, dextrin, Polyethylene Glycol and/or corresponding correctives etc., can make parvovirus Detection of antigen feminine gender, thereby treatment is because of infecting symptom that parvovirus causes.Good effect of the present invention is to have evident in efficacy, high safety, characteristics such as easy and simple to handle.
Those skilled in the art can expect, use the organic or inorganic solvent to extract to the Rhizoma valerianae latifoliae medical material, and extract also may be obtained better antiviral curative effect.As make methods such as water, ethanol, petroleum ether, carbon dioxide supercritical fluid extraction extract resulting extract.
Following examples are not for qualification of the present invention only as the explanation of effect of the present invention.
Embodiment 1: the capsular preparation of Rhizoma valerianae latifoliae:
1, will check medical material up to specification to select, remove impurity such as silt and dis-medicinal part, drain away the water after cleaning.
2, be cut into 2~3cm section, put in the baking oven 55~60 ℃ of dryings 4 hours, take out, pulverize the cooling back.
3, cross 65~80 mesh sieves, in the hermetic container of packing into, detect moisture, should be less than 10%, qualified back is standby.
4, recipe quantity starch is made 10% starch slurry after, join in the above-mentioned medicinal powder, mix thoroughly, the system soft material makes wet granular with the screen cloth about 14 orders.
5, the wet granular that makes is tiled in immediately in the oven dry pallet, thickness is dried 55~60 ℃ of humidity less than 2.5cm, and drying time is that moisture Control is 3~5% about 3.5~4 hours.
6, detect moisture qualified after, dried granule is sieved the granulate that sieves with 12 orders~16 purpose medicines.To be sub-packed in 0~No. 2 hungry area softgel shell through the Aranea smoked bean curd granule of arrangement.
Embodiment 2: the preparation of Rhizoma valerianae latifoliae tablet
1, will check Rhizoma valerianae latifoliae up to specification to select, remove impurity such as silt, drain away the water after cleaning.
2, be cut into 2~3cm section, put in the baking oven 55~60 ℃ of dryings 4 hours, take out, pulverize the cooling back.
3, cross 65~80 mesh sieves, in the hermetic container of packing into, detect moisture, should be less than 10%, qualified back is standby.
4, recipe quantity starch is made 10% starch slurry after, in the Aranea XIANGFEN: starch=0.7~0.9: 0.3~0.1 ratio joins in the Rhizoma valerianae latifoliae powder, mixes thoroughly, and the system soft material makes wet granular with the screen cloth about 14 orders.
5, the wet granular that makes is tiled in immediately in the oven dry pallet, thickness is dried 55~60 ℃ of humidity less than 2.5cm, and drying time is that moisture Control is 3~5% about 3.5~4 hours.
6, detect moisture qualified after, tabletting is promptly.
Embodiment 3 Rhizoma valerianae latifoliae capsules are to the observation of curative effect of canine parvovirus disease
1, the negative dog of 2~3 monthly age of animal grouping parvovirus antibody is 30, buys back 1 week of breeding observing, is divided into 3 groups at random, 10 every group, is respectively the treatment group, keeps to treat and shine and the counteracting toxic substances matched group.
2, the counteracting toxic substances method is pressed the 1ml/kg body weight with the strong venom of Canine Parvovirus and is given experimental dog oral.
3, medication counteracting toxic substances observation experiment every day dog clinical manifestation, disease symptom appears and after, according to the form below carries out administration.
The grouping of table 1 dosage
Grouping Dosage Administration number of times
The treatment group 50mg·kg -1·d -1 3-7 days continuously
Keep the treatment group Celebrate big toxin 2.5~4.5mgkg -1·d -1Sodium bicarbonate 1g 5% sugar-salt-water 100ml 3-7 days continuously
The counteracting toxic substances matched group Do not have Do not have
4, after observation index counteracting toxic substances and the administration, every day observation/determination experiment dog appetite, drinking-water, defecation, body temperature, body weight and feces toxin expelling situation.
5, availability deciding standard
Cure: 5-7 days appetite, body temperature, defecation are normal continuously, Canine Parvovirus Detection of antigen feminine gender.
Take a turn for the better: 3-5 days appetite, body temperature, defecation are normal continuously, and body weight is stable or increase.
Invalid: the experimental dog clinical symptoms worsens, and body weight continues to descend, and anorexia or do not eat is thin and weak or dead.
6, evaluating drug effect
Medicine effective percentage=(curing number+good revolution)/morbidity number * 100%.
7, result of the test
The grouping of table 1 dosage
Grouping Cure number Good revolution Morbidity/death toll Effective percentage
The treatment group 8 2 0/0 100%
Positive drug group (gentamycin) 2 3 5/0 50%
The counteracting toxic substances matched group - - 6/4 -
Experimental result shows that this capsule can effectively treat canine parvovirus disease, and therapeutic effect is better than conventional maintenance therapy.

Claims (2)

1. the application of Rhizoma valerianae latifoliae in preparation anti-dog parvovirus medicine.
2. medicine according to claim 1, it is characterized in that be by Rhizoma valerianae latifoliae can give separately or and acceptable accessories be prepared from oral formulations and give dog.
CN2010101698120A 2010-05-12 2010-05-12 Application of valeriana jatamansi jones to preparation of anti-canine parvovirus medicament Pending CN102240308A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010101698120A CN102240308A (en) 2010-05-12 2010-05-12 Application of valeriana jatamansi jones to preparation of anti-canine parvovirus medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010101698120A CN102240308A (en) 2010-05-12 2010-05-12 Application of valeriana jatamansi jones to preparation of anti-canine parvovirus medicament

Publications (1)

Publication Number Publication Date
CN102240308A true CN102240308A (en) 2011-11-16

Family

ID=44958668

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010101698120A Pending CN102240308A (en) 2010-05-12 2010-05-12 Application of valeriana jatamansi jones to preparation of anti-canine parvovirus medicament

Country Status (1)

Country Link
CN (1) CN102240308A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1634370A (en) * 2004-11-03 2005-07-06 车维新 Spider aroma preparation for treating diarrhea and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1634370A (en) * 2004-11-03 2005-07-06 车维新 Spider aroma preparation for treating diarrhea and preparation method thereof

Similar Documents

Publication Publication Date Title
Patel et al. Therapeutic opportunities of edible antiviral plants for COVID-19
CN103893272B (en) A kind of pharmaceutical composition and preparation method for the treatment of livestock dysentery
CN103006792A (en) Veterinary drug for preventing livestock bowel diseases, preparation method of drug, and feed
CN103006916A (en) Pure traditional Chinese medicine recipe for curing various animal diarrhoeal diseases and preparation method of pure traditional Chinese medicine recipe
CN113546119A (en) Application of Jingfang preparation in preparing anti-coronavirus medicine and preparation method thereof
CN104257704A (en) Novel application of eurycoma longifolia extracts
CN117343211A (en) Dendrobium polysaccharide and ROS response released dendrobe polysaccharide nano-carrier for preventing and treating ulcerative colitis
CN103202909B (en) Traditional Chinese medicine feed additive for preventing and curing diarrhea of livestock and poultry as well as fur-bearing animals
CN1803179B (en) Traditional Chinese medicine composition and its preparation method and quality control method
CN114470042B (en) Composition for preventing and treating liver injury of animals as well as preparation method and application thereof
CN103055031B (en) Pure Chinese medicinal composition for treating lime disease of bees and preparation method of pure Chinese medicinal composition
CN102240308A (en) Application of valeriana jatamansi jones to preparation of anti-canine parvovirus medicament
CN104758517A (en) A medicine composition for treating xenorhabdus infection of livestock and poultry
CN103463395A (en) Pharmaceutical formulation for treating respiratory disease of chickens
CN113350429A (en) Traditional Chinese medicine composition for preventing and treating African swine fever disease and preparation method and application thereof
CN102697887A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis
CN103040949A (en) Drug for treating cold and preparation method thereof
CN103142766A (en) Medicine for controlling coccidiosis in rabbits
CN113577187A (en) Anti-influenza traditional Chinese medicine composition, traditional Chinese medicine extract and preparation method and application thereof
CN103203004B (en) Medicinal composition with dysentery stopping effect and preparation method thereof
Jiang et al. A review on application of Chinese herbal medicine additives in immunization of aquatic animals
CN104547898A (en) Formula of eimeria tenella disease resistant traditional Chinese medicine with fresh bamboo juice as main ingredient
CN1660350A (en) Combination of medication of containing medicinal rhubarb and activated carbon or carbo medicinalis
CN111135165B (en) Use of aesculetin and its prescription in preparation of medicine for treating livestock diarrhea
CN107519269A (en) A kind of de- mould detoxification Chinese traditional medicine powder for animals and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20111116